Product image of Minirin (Desmopressin Acetate) supplied by GNH India

Minirin

Active Ingredient:
Desmopressin Acetate
Origin:
EU

Minirin (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Minirin, is a vasopressin analog presented as an injection solution for intramuscular, intravenous, or subcutaneous use. It is employed to manage central diabetes insipidus, nocturnal enuresis in children, and to raise factor VIII and von Willebrand factor levels in hemophilia A and von Willebrand disease.

GNH India supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and transplant centres worldwide, with full regulatory documentation and cold‑chain logistics where required, ensuring product integrity from manufacture to delivery.

Manufacturer / TM Owner

Ferring N.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Desmopressin acetate is a synthetic vasopressin analog that acts on the antidiuretic hormone pathway.
  • Central diabetes insipidus: reduces excessive urine output by increasing water reabsorption in the kidneys.
  • Nocturnal enuresis: decreases nighttime bedwetting by concentrating urine.
  • Hemophilia A: raises plasma factor VIII levels to improve clotting.
  • Von Willebrand disease: enhances release of von Willebrand factor to support hemostasis.

How It Works

  • Desmopressin acetate is a synthetic analogue of vasopressin that selectively stimulates V2 receptors in the renal collecting ducts, promoting insertion of aquaporin‑2 channels and increasing water reabsorption. It also activates V1 receptors on endothelial cells, triggering release of von Willebrand factor and factor VIII, thereby improving hemostatic function.

Side Effects

Desmopressin acetate may cause several adverse reactions, ranging from mild to serious.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Nausea or abdominal cramps: transient gastrointestinal discomfort.
  • Hyponatremia: mild reduction in serum sodium.
  • Flushing or facial warmth: short‑lasting vasodilation.
  • Mild hypotension: temporary drop in blood pressure.

Serious or Rare Side Effects

  • Severe hyponatremia leading to seizures or coma.
  • Water intoxication with cerebral edema.
  • Allergic reactions such as rash, itching, or anaphylaxis.
  • Thrombotic events in patients with pre‑existing clotting disorders.

Precautions & Warnings

  • Before using Minirin, consider the following safety measures.
  • Renal function: monitor serum sodium and fluid balance regularly.
  • Cardiovascular status: use caution in patients with hypertension or heart failure.
  • Age considerations: elderly patients may require closer observation for hyponatremia.
  • Concomitant drugs: avoid simultaneous use of other antidiuretic agents.
  • Pregnancy and lactation: safety not established; weigh benefits against potential risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Desmopressin acetate can interact with several medicines, requiring attention to potential additive effects.

Major Interactions (Avoid)

  • Other ADH analogues: risk of severe hyponatremia.
  • Thiazide diuretics: increase likelihood of low sodium levels.
  • NSAIDs: may potentiate antidiuretic action.

Moderate Interactions (Monitor Closely)

  • Alcohol: can exacerbate hyponatremia.
  • SSRIs or other antidepressants: additive effect on sodium balance.
  • ACE inhibitors: monitor blood pressure and renal function.

Frequently Asked Questions

Minirin contains desmopressin acetate and is prescribed for central diabetes insipidus, nocturnal enuresis in children, and to increase factor VIII and von Willebrand factor levels in patients with hemophilia A or von Willebrand disease.

Desmopressin acetate mimics the natural hormone vasopressin. It binds to V2 receptors in the kidney, enhancing water reabsorption, and to V1 receptors on endothelial cells, stimulating release of von Willebrand factor and factor VIII, thereby supporting clot formation.

The dose of Minirin is individualized by the prescribing clinician based on the patient’s condition, age, weight, and response. Only a qualified health professional should determine the appropriate regimen.

Safety data for desmopressin acetate in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a healthcare provider.

To order Minirin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where needed) and import documentation.

Minirin (desmopressin) is a synthetic analogue of vasopressin with greater selectivity for V2 receptors, offering a longer duration of action and fewer cardiovascular effects than natural vasopressin (Pitressin). This makes it the preferred choice for chronic conditions like diabetes insipidus and bleeding disorders.

Minirin should be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the vial. If temporary storage at room temperature is unavoidable, limit exposure to less than 24 hours and keep the product in its original container.

Minirin is supplied as an injectable solution and can be given intramuscularly, intravenously, or subcutaneously. The route and injection technique are determined by the prescriber and should follow aseptic guidelines.

The most critical safety concerns are severe hyponatremia and water intoxication, which can lead to seizures, cerebral edema, or coma. Prompt monitoring of serum sodium and fluid intake is essential, especially in high‑risk patients.

Minirin is contraindicated in patients with known hypersensitivity to desmopressin, uncontrolled hyponatremia, severe renal impairment, or conditions predisposing to water retention such as uncontrolled heart failure. Clinicians should assess each patient’s medical history before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Desmopressin Acetate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT